Ningbo MedicalSystem Biotechnology Co Ltd (300439)

Currency in CNY
11.57
+0.17(+1.49%)
Delayed Data·
300439 Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
300439 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
11.3611.58
52 wk Range
8.6013.24
Key Statistics
Bid/Ask
11.56 / 11.57
Prev. Close
11.4
Open
11.38
Day's Range
11.36-11.58
52 wk Range
8.6-13.24
Volume
3.39M
Average Volume (3m)
5.56M
1-Year Change
25.91%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
300439 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Has raised its dividend for 3 consecutive years

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell

Ningbo MedicalSystem Biotechnology Co Ltd Company Profile

Medicalsystem Biotechnology Co., Ltd. engages in the research, development, production, and sales of in vitro diagnostic products in China. It is also involved in the provision of Three-party medical diagnosis services. The company offers automated biochemistry analyzers and bio reagents; and automated chemiluminescence immunoassay analyzer; hematology analyzers and reagents; and glycated hemoglobin analyzer, blood lipid analyzer, POCT, microfluidic biochemical analyzer. The company also provides urine analyzers, urine sediment analyzers; PCR kit, antibody test kit, antigen and antibody test kit, and nucleic acid reagent for COVID-19. It also provides healthcare services. Medicalsystem Biotechnology Co., Ltd. was formerly known as Ningbo Medicalsystem Biotechnology Co., Ltd. and changed its name to Biotechnology Co., Ltd. in January 2017. Medicalsystem Biotechnology Co., Ltd. was founded in 2003 and is based in Ningbo, China.

Employees
2104
Market
China

Compare 300439 to Peers and Sector

Metrics to compare
300439
Peers
Sector
Relationship
P/E Ratio
21.3x40.4x−0.5x
PEG Ratio
−0.98−0.780.00
Price/Book
1.5x2.4x2.6x
Price / LTM Sales
2.7x7.7x3.3x
Upside (Analyst Target)
-1.1%40.6%
Fair Value Upside
Unlock9.1%5.3%Unlock

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 0.54%
Dividend Yield
1.18%
Industry Median 1.78%
Annualised payout
0.13
Paid annually
5-Years Growth
-
Growth Streak

Earnings

Latest Release
Apr 25, 2025
EPS / Forecast
0.08 / --
Revenue / Forecast
374.03M / --
EPS Revisions
Last 90 days

300439 Income Statement

FAQ

What Stock Exchange Does Ningbo MedicalSystem Biotech Trade On?

Ningbo MedicalSystem Biotech is listed and trades on the Shenzhen Stock Exchange stock exchange.

What Is the Stock Symbol for Ningbo MedicalSystem Biotech?

The stock symbol for Ningbo MedicalSystem Biotech is "300439."

What Is the Ningbo MedicalSystem Biotech Market Cap?

As of today, Ningbo MedicalSystem Biotech market cap is 4.45B.

What Is Ningbo MedicalSystem Biotech's Earnings Per Share (TTM)?

The Ningbo MedicalSystem Biotech EPS (TTM) is 0.54.

From a Technical Analysis Perspective, Is 300439 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.

How Many Times Has Ningbo MedicalSystem Biotech Stock Split?

Ningbo MedicalSystem Biotech has split 1 times.

How Many Employees Does Ningbo MedicalSystem Biotech Have?

Ningbo MedicalSystem Biotech has 2104 employees.

What is the current trading status of Ningbo MedicalSystem Biotech (300439)?

As of 15 Aug 2025, Ningbo MedicalSystem Biotech (300439) is trading at a price of 11.57, with a previous close of 11.40. The stock has fluctuated within a day range of 11.36 to 11.58, while its 52-week range spans from 8.60 to 13.24.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.